Immunization Cooperative Agreements
To assist states and communities in establishing and maintaining preventive health service programs to immunize individuals against vaccine-preventable diseases (including measles, rubella, poliomyelitis, diphtheria, pertussis, tetanus, hepatitis B, hepatitis A, varicella, mumps, haemophilus influenza type b, influenza, and pneumococcal pneumonia).
General information about this opportunity
Last Known Status
Centers For Disease Control and Prevention, Department of Health and Human Services
Type(s) of Assistance Offered
B - Project Grants
Section 317(j) of the Public Health Service Act (42 U.S.C. 247b(j)) reauthorized in Section 4204 of the Patient Protection and Affordable Care Act. Prevention and Public Health Fund (PPHF) funding is authorized under sections 301 and 317 of the Public Health Service Act (PHS Act), 42 USC, 241 and 247b as amended and the Patient Protection and Affordable Care Act (PL 111-148). The Vaccines for Children (VFC) program is authorized under Section 1902(a)(62) of the Social Security Act, 42 U.S.C. section 1396a(a)(62). The VFC Program was established under the authority of Section 1928(a) of the Social Security Act, 42 U.S.C. 1396s(a).
Who is eligible to apply/benefit from this assistance?
Any U.S. state, and in consultation with state health authorities, political subdivisions of states and other public entities and U.S. territories may apply; private individuals and private nonprofit agencies are not eligible for immunization grants.
Any U.S. state, political subdivision (as described above), and other public entities will benefit.
Applicants should document the need for assistance, state the objectives of the project, outline the method of operation, describe the evaluation procedures, and provide a budget with justification of funds. Costs will be determined in accordance with 2 CFR 225 (OMB Circular No. A-87) for state and local governments.
What is the process for applying and being award this assistance?
Preapplication coordination is required. This program is eligible for coverage under E.O. 12372, "Intergovernmental Review of Federal Programs." An applicant should consult the office or official designated as the single point of contact in his or her State for more information on the process the State requires to be followed in applying for assistance, if the State has selected the program for review. Contact the headquarters or regional location, as appropriate, for application deadlines.
2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. Information on the submission of applications may be obtained from the Grants Management Officer, Grants Management Branch, Procurement and Grants Office, Centers for Disease Control and Prevention. Telephone: (770) 488-2716. This program is subject to the provisions of 45 CFR 92. The standard application forms, as furnished by PHS and required by 45 CFR 92 for state and local governments, must be used for this program.
After review and approval of an application, a Notice of Award is prepared and processed, along with appropriate notification to the public.
Contact the headquarters or regional location, as appropriate for application deadlines
Approval/Disapproval Decision Time
From 60 to 90 days. From 90 to 120 days
How are proposals selected?
How may assistance be used?
Cooperative Agreement funds may be used for costs associated with planning, organizing, and conducting immunization programs directed toward vaccine-preventable diseases and for the purchase of vaccine; and for the implementation of other program elements, such as assessment of the problem; surveillance and outbreak control; information and education; adequate notification of the risks and benefits of immunization; compliance with compulsory school immunization laws; vaccine storage, supply management, and delivery; citizen participation; and use of volunteers. Vaccine will be available "in lieu of cash" if requested by the applicants. Requests for personnel and other items "in lieu of cash" will also be considered. Vaccine purchased with Cooperative Agreement funds may be provided to private practitioners who agree not to charge for vaccine. Cooperative Agreement funds may be used to supplement (not substitute for) existing immunization services and operations provided by a state or locality.
What are the requirements after being awarded this opportunity?
In addition, grants and cooperative agreements are subject to inspection and audits by DHHS and other Federal government officials.
Financial records, supporting documents, statistical records, and all other records pertinent to the grant program shall be retained for a minimum of 3 years, or until completion and resolution of any audit in process or pending resolution. In all cases records must be retained until resolution of any audit questions. Property records must be retained in accordance with PHS Grants Policy Statement requirements.
Other Assistance Considerations
Formula and Matching Requirements
Statutory formula is not applicable to this assistance listing.
Matching requirements are not applicable to this assistance listing.
MOE requirements are not applicable to this assistance listing.
Length and Time Phasing of Assistance
Project Period: Variable. Budget Period: About 12 months. Periodic grant rounds
Who do I contact about this opportunity?
Regional or Local Office
1600 Clifton Road MSA19
Atlanta, GA 30333 US
(Cooperative Agreements) FY 18$330,791,211.00; FY 19 est $4,422,030,680.00; FY 20 est $389,151,364.00; FY 17$145,052,647.00; FY 16$151,109,102.00; -
Range and Average of Financial Assistance
317 Grants: From $252,725 to $48,568,982; $6,870,723 VFC Grants: From $1,649,229 to $368,026,903; $52,334,322.
Regulations, Guidelines and Literature
Examples of Funded Projects